Wed, May 11, 2022
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022

Gena Wang Maintained (ARCT) at Sell with Decreased Target to $17 on, May 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-17-on-may-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gena Wang of Barclays, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Sell with Decreased Target from $21 to $17 on, May 10th, 2022.

Gena has made no other calls on ARCT in the last 4 months.



There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 1 agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


These are the ratings of the 2 analyists that currently disagree with Gena


  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $105 on, Friday, March 25th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $86 on, Tuesday, March 15th, 2022

Publication Contributing Sources